Additional file 3: of Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
Label: Estimated HRs (with 95% CIs) of OC death in relation to cumulative use of medications. Fitted curves are cubic splines, with inner knots at 1.5 and 3 years, estimated from a mutually adjusted Cox regression model. OC ovarian cancer, HR hazard ratio, 95% CI 95% confidence interval, DDD defined daily dose. (PDF 251 kb
